Proto Labs reported a revenue of $106.6 million for Q2 2020, representing an 8.1 percent decrease compared to Q2 2019. GAAP EPS was $0.47, and non-GAAP EPS was $0.59. The company delivered over 8 million parts to support the medical industry, generating $12 million in revenue.
Revenue for the second quarter of 2020 was $106.6 million, an 8.1 percent decrease compared to Q2 2019.
Net income for the second quarter of 2020 was $12.6 million, or $0.47 per diluted share.
Non-GAAP net income was $15.9 million, or $0.59 per diluted share.
The company generated $31.0 million in cash from operations during the second quarter of 2020.
Analyze how earnings announcements historically affect stock price performance